Syros Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
60,393.00
35,909.00
83,593.00
72,242.00
100,317
Total Accounts Receivable
-
-
867.00
-
-
Other Current Assets
150.00
540.00
1,048.00
917.00
1,417
Total Current Assets
60,543.00
36,449.00
85,508.00
73,159.00
101,734
Net Property, Plant & Equipment
881.00
4,799.00
4,850.00
3,938.00
3,861
Total Investments and Advances
70.00
483.00
483.00
290.00
290
Other Assets
-
1,900.00
482.00
1,101.00
881
Total Assets
61,494.00
43,631.00
91,323.00
78,488.00
106,766
ST Debt & Current Portion LT Debt
-
133.00
168.00
47.00
Accounts Payable
-
-
2,415.00
2,283.00
Other Current Liabilities
1,252.00
7,823.00
6,984.00
10,083.00
Total Current Liabilities
1,252.00
7,956.00
9,567.00
12,413.00
Long-Term Debt
-
206.00
53.00
6.00
Other Liabilities
1.00
1,420.00
1,101.00
745.00
Total Liabilities
1,253.00
9,582.00
10,721.00
13,164.00
Common Equity (Total)
21,772.00
47,964.00
80,602.00
65,324.00
Total Shareholders' Equity
60,241.00
34,049.00
80,602.00
65,324.00
Total Equity
60,241.00
34,049.00
80,602.00
65,324.00
Liabilities & Shareholders' Equity
61,494.00
43,631.00
91,323.00
78,488.00
Preferred Stock (Carrying Value)
82,013.00
82,013.00
-
-
About Syros Pharmaceuticals
View Profile
